Anxiety and Depression in Patients Hospitalizes for an Acute Exacerbation of COPD
NCT ID: NCT01520376
Last Updated: 2018-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
169 participants
INTERVENTIONAL
2011-10-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Consultation Liaison and Integrated Care for COPD Patients With Psychiatric Co-Morbidity"
NCT01644916
Secondary Prevention of Problems in Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00940355
Cognitive Behavioral Therapy for Anxiety and Depression in COPD
NCT00545922
Assessment of Stress Levels and Depressive and Anxiety Symptoms in Patients With COPD
NCT04726917
Evaluation of Depression In Chronic Obstructive Pulmonary Disease
NCT02147912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Counselling
People receiving a psychiatric evaluation after screening (HADS test \> 12 points) and revised at 1 and 6 months
Counselling
Visit by a psychiatrist at day-30 and day-180 after discarge
Usual care
People after screening (HADS test \> 12 points) and send to their primary care physician
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Counselling
Visit by a psychiatrist at day-30 and day-180 after discarge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Above 40 years old
* Diagnose with Chronic Obstructive Pulmonary disease (COPD) according to the ATS/ERS guidelines
* Acute exacerbation of COPD according to the following criteria:
a) Cyanosis b) Obnubilations or mental confusion d) Respiratory Rate above 25 per minute e) Failure of ambulatory treatment f) Co-morbidities that worsens respiratory condition g) Dyspnea
Exclusion Criteria
* Needing of mechanical ventilation
* Severe cardiovascular disease
* Pregnancy
* Previous diagnosis of depression/anxiety
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nestor Soler Porcar, MD, PhD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nestor Soler Porcar, MD, PhD
Especialista Sènior
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arturo Huerta, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Clinic of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundacio Clinic Per la Recerca Biomèdica - Hospital Clinic de Barcelona
Barcelona, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ADPHA-EPOC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.